Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease

Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease have?

Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease has 147 citations in the OpenAlex counts ScholarIQ stores.

When was Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease published?

Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease has 2018 year in the ScholarIQ index.

What is the open-access status of Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease?

Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease has closed oa status in the ScholarIQ index.

What is the DOI of Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease?

The DOI for Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease is on the source record.

What is the PMID of Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease?

The PMID for Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease is on the source record.

What is the OpenAlex record for Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease?

The OpenAlex for Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease is on the source record.